EMILY BOUDREAU
Physician Assistant in WEYMOUTH, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
EMILY BOUDREAU reported a CMS MIPS final score of 82.7866/100 — below the 83.1 national average — and filed 802 Medicare Part D claims in 2023.
- 82.7866/100
- MIPS score · 0 vs avg
- 802
- Part D claims, 2023
- 80%
- generic prescribing
- $288.87
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
EMILY BOUDREAU's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
83 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about EMILY BOUDREAU?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Physician Assistant compares to other specialties among Massachusetts providers
Physician Assistant share within Massachusetts
Physician Assistant is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
EMILY BOUDREAU's 2023 MIPS final score plotted against the Physician Assistant national average
- MIPS Final Score
- 82.7866/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Physician Assistant) — 82.7866/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Physician Assistant US NPIs
82.7866/100 MIPS final score — 0.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Physician Assistant. Quality dim: 88.3333. Cost dim: 69.5333.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
EMILY BOUDREAU appears in the CMS NPPES registry as a Physician Assistant provider at 101 COLUMBIAN ST, WEYMOUTH, MA, 02190, with a listed phone of (781) 624-5000. NPI 1487213021 was issued on 06/07/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOUDREAU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 802 prescription claims written by this provider, covering 231 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 8.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.7866/100 for the 2023 performance year (Quality 88.3333, Cost 69.5333), compared with the national average of 83.1.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487213021 |
|---|---|
| Specialty | Physician Assistant |
| Gender | Female |
| NPI Issued | 06/07/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm EMILY BOUDREAU's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EMILY BOUDREAU. Source: openpaymentsdata.cms.gov.
Total received
$289
Largest payer
Mirati Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to EMILY BOUDREAU. To verify EMILY BOUDREAU's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
20% brand-name claims vs 80% generic, on 802 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,173
- Total Day Supply
- 30,788
- Brand vs Generic
- 20% brand / 80% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $137K
- Opioid Claims
- 70 (8.7% rate)
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 2.32
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 27, 65-74: 97, 75-84: 93, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What EMILY BOUDREAU prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
54 claims
- Anastrozole
Anastrozole
44 claims
- Letrozole
Letrozole
44 claims
- Abiraterone Acetate
Abiraterone Acetate
39 claims
- Ondansetron Odt
Ondansetron Odt
38 claims
- Oxycodone Hcl
Oxycodone Hcl
37 claims
- Lorazepam
Lorazepam
27 claims
- Prochlorperazine M…
Prochlorperazine Maleate
26 claims
| Drug | Claims |
|---|---|
| Gabapentin | 54 |
| Anastrozole | 44 |
| Letrozole | 44 |
| Abiraterone Acetate | 39 |
| Ondansetron Odt Ondansetron | 38 |
| Oxycodone Hcl | 37 |
| Lorazepam | 27 |
| Prochlorperazine Maleate | 26 |
| Eliquis Apixaban | 25 |
| Prednisone | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How EMILY BOUDREAU fits within the Physician Assistant landscape nationally.
EMILY BOUDREAU's 802 claims are above the specialty average of 790.
Nearby Physician Assistant Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BOUDREAU.
Compare Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is EMILY BOUDREAU's specialty? ▼
How much does EMILY BOUDREAU prescribe under Medicare Part D? ▼
What is EMILY BOUDREAU's Medicare quality score? ▼
Where is EMILY BOUDREAU located? ▼
What is EMILY BOUDREAU's NPI number? ▼
Does EMILY BOUDREAU prescribe more brand-name or generic drugs? ▼
Does EMILY BOUDREAU prescribe opioids? ▼
How many Physician Assistant providers are there in the US? ▼
What drugs does EMILY BOUDREAU prescribe most often? ▼
Does EMILY BOUDREAU accept Medicare? ▼
How can I verify EMILY BOUDREAU's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology